Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (54,225)	$ (27,466)
Other comprehensive income (loss):
Available for sale securities - net unrealized gain (loss)	52	(57)
Cumulative translation adjustment arising during the period	(11)	0
Total other comprehensive income (loss)	41	(57)
Comprehensive loss	(54,184)	(27,523)
Comprehensive income (loss) attributable to noncontrolling interests	0	0
Comprehensive loss attributable to Lisata Therapeutics, Inc. common stockholders	$ (54,184)	$ (27,523)